Welcome to Autonomic Technologies

Autonomic Technologies, Inc. (ATI) is a San Francisco Bay Area based medical device company backed by blue chip investors Kleiner Perkins Caufield and Byers, InterWest Partners, Versant Ventures, Novartis Ventures, Aberdare Ventures, and the Cleveland Clinic. Named by Medical Device & Diagnostic Industry (MD+DI) as one of the 2010 50 Companies to Watch, MD+DI reports ATI is "led by management with success in medical implants as well as investment teams who believe ATI's product will be the next big thing in the neurotechnology industry."

Founded in 2007, the ATI team is pioneering a miniaturized implantable neurostimulation device to provide rapid relief from the debilitating pain and suffering caused by severe headaches. The ATI neurostimulation system is being used in clinical studies for cluster headache and migraine. Our passion and motivation is to provide a long term solution to headache sufferers worldwide, so they can enjoy a better quality of life.